eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2024
vol. 16
 
Share:
Send email
Share:
Original paper

Indian Brachytherapy Society consensus recommendations for brachytherapy in breast cancer

Daya Nand Sharma
1
,
Ashwini Budrukkar
2
,
Rishabh Kumar
1
,
Tabassum Wadasadawala
2
,
Rajiv Sarin
2
,
Rituraj Upreti
2
,
Ashish Binjola
1
,
Umesh Mahantshetty
3
,
SVS Deo
4
,
Rajendra Badwe
5

  1. Department of Radiation Oncology, AIIMS, New Delhi, India
  2. Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India
  3. Department of Radiation Oncology, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, India
  4. Department of Surgical Oncology, AIIMS, New Delhi, India
  5. Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
J Contemp Brachytherapy 2024; 16, 4: 257-267
DOI: https://doi.org/10.5114/jcb.2024.142936
Online publish date: 2024/09/12
Article file
- Indian Brachytherapy Society.pdf  [0.42 MB]
Get citation
 
 
1. Polgár C, Ott OJ, Hildebrandt G et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol 2017; 18: 259-268.
2. Strnad V, Polgár C, Ott OJ et al. Groupe Européen de Curiethérapie and European Society for Radiotherapy and Oncology. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial. Lancet Oncol 2023; 24: 262-272.
3. Hannoun-Levi JM, Resch A, Gal J et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: Multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol 2013; 108: 226-231.
4. Guinot JL, Baixauli-Perez C, Soler P et al. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer. Int J Radiat Oncol Biol Phys 2015; 91: 165-171.
5. Lettmaier S, Kreppner S, Lotter M et al. Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: A dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. Radiother Oncol 2011; 100: 189-194.
6. Major T, Gutiérrez C, Guix B et al. Interobserver variations of target volume delineation in multicatheter partial breast brachytherapy after open cavity surgery. Brachytherapy 2015; 14: 925-932.
7. Ott OJ, Schulz-Wendtland R, Uter W et al. Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer. Strahlenther Onkol 2005; 181: 638-644.
8. Ott OJ, Hildebrandt G, Pötter R et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 2007; 82: 281-286.
9. Polgár C, Major T, Fodor J et al. Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 2010; 94: 274-279.
10. Polgár C, Major T, Takácsi-Nagy Z et al. Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study. Int J Radiat Oncol Biol Phys 2021; 109: 998-1006.
11. Aristei C, Maranzano E, Lancellotta V et al. Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study. Radiother Oncol 2017; 124: 208-213.
12. Murray Brunt A, Haviland JS, Wheatley DA et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet 2020; 395: 1613-1626.
13. Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241.
14. Blichert-Toft M, Brincker H, Andersen JA et al. A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma: Preliminary results. Acta Oncol (Madr) 1988; 27: 671-677.
15. Lichter AS, Lippman ME, Danforth DN et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. J Clin Oncol 1992; 10: 976-983.
16. Jacobson JA, Danforth DN, Cowan KH et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332: 907-911.
17. van Dongen JA, Bartelink H, Fentiman IS et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992; 28: 801-805.
18. Veronesi U, Saccozzi R, Del Vecchio M et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981; 305: 6-11.
19. Schroen AT, Brenin DR, Kelly MD et al. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 2005; 23: 7074-7080.
20. Chatterjee S. Is India overdoing mastectomy? Indian J Surg 2020; 1-3.
21. Hassan Ali S, Somashekhar SP, Arun Kumar N. Rate of breast-conserving surgery vs mastectomy in breast cancer: A tertiary care centre experience from South India. Indian J Surg Oncol 2019; 10: 72-76.
22. Showalter SL, Grover S, Sharma S et al. Factors influencing surgical and adjuvant therapy in stage i breast cancer: A SEER 18 database analysis. Ann Surg Oncol 2013; 20: 1287-1294.
23. Jacobs LK, Kelley KA, Rosson GD et al. Disparities in urban and rural mastectomy populations: The effects of patient- and county-level factors on likelihood of receipt of mastectomy. Ann Surg Oncol 2008; 15: 2644-2652.
24. Budrukkar A, Telkhade T, Wadasadawala T et al. A comparison of long-term clinical outcomes of accelerated partial breast irradiation using interstitial brachytherapy as per GEC-ESTRO, ASTRO, updated ASTRO, and ABS guidelines. Brachytherapy 2020; 19: 337-347.
25. Goulding A, Asmar L, Wang Y et al. Outcomes after accelerated partial breast irradiation in women with triple negative subtype and other “high risk” variables categorized as cautionary in the ASTRO guidelines. Front Oncol 2021; 11: 617439.
26. Vicini F, Cecchini R, White J et al. Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer 2019:GS4-04-GS4-04.
27. Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001; 12: 997-1003.
28. Clark RM, Mcculloch PB, Levine MN et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992; 84: 683-689.
29. Liljegren G, Holmberg L, Bergh J et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999; 17: 2326-2633.
30. Vicini FA, Antonucci JV, Wallace M et al. Long-term efficacy and patterns of failure after accelerated partial breast irradiation: A molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys 2007; 68: 341-346.
31. Perera F, Yu E, Engel J et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up. Int J Radiat Oncol Biol Phys 2003; 57: 1239-1246.
32. Imamura H, Haga S, Shimizu T et al. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 2000; 62: 177-184.
33. Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001; 12: 997-1003.
34. Vicini FA, Cecchini RS, White JR et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet 2019; 394: 2155-2164.
35. Goulding A, Asmar L, Wang Y et al. Outcomes after accelerated partial breast irradiation in women with triple negative subtype and other “high risk” variables categorized as cautionary in the ASTRO Guidelines. Front Oncol 2021; 11: 428.
36. Wadasadawala T, Mondal M, Paul SN et al. Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort. J Contemp Brachytherapy 2018; 10: 47-57.
37. Saini A, Kuske R, Quiet C et al. Outcomes by molecular subtype after accelerated partial breast irradiation using single-entry catheters. Brachytherapy 2018; 17: 415-424.
38. Budrukkar A, Gurram L, Upreti RR et al. Clinical outcomes of prospectively treated 140 women with early stage breast cancer using accelerated partial breast irradiation with 3 dimensional computerized tomography based brachytherapy. Radiother Oncol 2015; 115: 349-354.
39. Romestaing P, Lehingue Y, Carrie C et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15: 963-968.
40. Polgár C, Fodor J, Orosz Z et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: First results of the randomized Budapest boost trial. Strahlenther Onkol 2002; 178: 615-623.
41. Bartelink H, Horiot JC, Poortmans PM et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25: 3259-3265.
42. Poortmans P, Bartelink H, Horiot JC et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC “boost versus no boost” randomised trial. Radiother Oncol 2004; 72: 25-33.
43. Smitt MC, Birdwell RL, Goffinet DR. Breast electron boost planning: Comparison of CT and US. Radiology 2001; 219: 203-206.
44. Fitzal F, Nehrer G, Hoch D et al. An oncoplastic procedure for central and medio-cranial breast cancer. Eur J Surg Oncol 2007; 33: 1158-1163.
45. Fitzal F, Nehrer G, Deutinger M et al. Novel strategies in oncoplastic surgery for breast cancer: Immediate partial reconstruction of breast defects. Eur Surg Acta Chirurgica Austriaca 2007; 39: 330-339.
46. Baso Bapras. Oncoplastic breast surgery – A guide to good practice. Eur J Surg Oncol 2007; 33.
47. Roth AM, Kauer-Dorner D, Resch A et al. Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method? Brachytherapy 2014; 13: 394-399.
48. Gurram L, Wadasadawala T, Joshi K et al. Multi-catheter interstitial brachytherapy for partial breast irradiation: an audit of implant quality based on dosimetric evaluation comparing intra-operative versus post-operative placement. J Contemp Brachytherapy 2016; 8: 116-121.
49. Sharma SD, Budrukkar A, Upreti RR et al. Dosimetric comparison of conventional radiograph- and three-dimensional computed tomography-based planning using dose volume indices for partial breast intraoperative implants. Clin Oncol 2008; 20: 46-52.
50. Narayanan SS, Goel V, Sarin R et al. Intraoperative high-dose-rate 192Ir radical implant in early breast cancer: A quality assurance and dosimetry study. Int J Radiat Oncol Biol Phys 2003; 56: 690-696.
51. Budrukkar A, Pandit P, Wadasadawala T et al. Impact of adjuvant systemic chemotherapy on wound healing and cosmetic outcome in 224 women treated with accelerated partial breast irradiation using interstitial brachytherapy. Brachytherapy 2017; 16: 935-942.
52. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys 2004; 60: 722-730.
53. Kumar A, Wadasadawala T, Joshi K et al. What is the dosimetric impact of isotropic vs anisotropic safety margins for delineation of the clinical target volume in breast brachytherapy? Brachytherapy 2021; 20: 155-162.
54. Wadasadawala T, Bushra S, Gurram L et al. Is it important to define skin sub-volumes in breast brachytherapy? J Radiother Pract 2022; 21: 68-73.
55. Baltas D, Kolotas C, Geramani K et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998; 40: 515-524.
56. Genebes C, Chand ME, Gal J et al. Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy. Radiat Oncol 2014; 9: 115.
57. Perez CA. 3-47 accelerated partial breast irradiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Breast Dis 2006; 17: 274-275.
58. Garsa AA, Ferraro DJ, Dewees TA et al. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2013; 87: 1043-1050.
59. Upreti RR, Budrukkar A, Upreti U et al. Change of target volume and its dosimetric impact during the course of accelerated partial breast irradiation using intraoperative multicatheter interstitial brachytherapy after open cavity surgery. Brachytherapy 2017; 16: 1028-1034.
60. Strnad V, Major T, Polgar C et al. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations. Radiother Oncol 2018; 128: 411-420.
61. Polgár C, Fodor J, Major T et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007; 69: 694-702.
62. Strnad V, Ott OJ, Hildebrandt G et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: A randomised, phase 3, non-inferiority trial. Lancet 2016; 387: 229-238.
63. Ott OJ, Strnad V, Hildebrandt G et al. GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance. Radiother Oncol 2016; 120: 119-123.
64. Polgár C, Ott OJ, Hildebrandt G et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol 2017; 18: 259-268.
65. Polgár C, Van Limbergen E, Pötter R et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010; 94: 264-273.
66. White J, Winter K, Kuske RR et al. Long-term cancer outcomes from study NRG Oncology/RTOG 9517: A phase 2 study of accelerated partial breast irradiation with multicatheter brachytherapy after lumpectomy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2016; 95: 1460-1465.
67. Rabinovitch R, Winter K, Kuske R et al. RTOG 95-17, a phase II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma-year-5 toxicity and cosmesis. Brachytherapy 2014; 13: 17-22.
68. Hattangadi JA, Powell SN, MacDonald SM et al. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. Int J Radiat Oncol Biol Phys 2012; 83: 791-800.
69. Pennington JD, Park SJ, Abgaryan N et al. Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis. Brachytherapy 2015; 14: 537-542.
70. Xiang X, Ding Z, Feng L, Li N. A meta-analysis of the efficacy and safety of accelerated partial breast irradiation versus whole-breast irradiation for early-stage breast cancer. Radiat Oncol 2021; 16: 24.
71. Wadasadawala T, Sinha S, Parmar V et al. Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: a prospective propensity score-matched pair analysis. Breast Cancer 2020; 27: 206-212.
72. Wadasadawala T, Maitre P, Sinha S et al. Patient-reported quality of life with interstitial partial breast brachytherapy and external beam whole breast radiotherapy: a comparison using propensity-score matching. J Contemp Brachytherapy 2021; 13: 387-394.
73. Krishnamurthy R, Wadasadawala T, Rane P et al. Defining dose constraints for catheter insertion sites to minimize toxicity after interstitial breast brachytherapy. Brachytherapy 2020; 19: 694-699.
74. Korzets Y, Fyles A, Shepshelovich D et al. Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 2019; 175: 531-545.
75. Aristei C, Maranzano E, Lancellotta V et al. Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study. Radiother Oncol 2017; 124: 208-213.
76. Lövey K, Fodor J, Major T et al. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy-4-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007; 69: 724-731.
77. Budrukkar A, Jagtap V, Kembhavi S et al. Fat necrosis in women with early-stage breast cancer treated with accelerated partial breast irradiation (APBI) using interstitial brachytherapy. Radiother Oncol 2012; 103: 161-165.
78. Sharma DN, Deo SVS, Rath GK et al. Perioperative high-dose-rate interstitial brachytherapy boost for patients with early breast cancer. Tumori 2013; 99: 604-610.
79. Batra M, Sharma DN, Deo SVS. Interstitial brachytherapy for accelerated partial breast irrdiation or boost therapy in early breast cancer. Brachytherapy 2019; 18: S46-47.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.